Dr. Barnali Das did her MBBS from Lady Hardinge Medical College, Delhi and MD and DNB (Biochemistry)
from Maulana Azad Medical College, Delhi. Subsequently, she has done management development training from IIT Bombay, and
also pursued courses in Clinical Trial and PGDM in Hospital & Health Care Management from Symbiosis, Pune.
From October, 2008, she has been a consultant in Biochemistry & Immunology divisions of
Kokilaben Dhirubhai Ambani hospital (KH) & medical research institute, Mumbai. Prior to joining KH, she
was supervising Biochemistry and RIA Chemiluminescense divisions of SRL Ranbaxy, Mumbai. Earlier she was a lecturer in T.N.M.C.
& Nair Hospital, Mumbai and senior resident in MAMC and Safdarjung Hospital, Delhi.
She has worked on biomarkers
of coronary artery disease and nanotechnology. She has been honoured with three prestigious international and three national
awards from American Association of Clinical Chemistry (AACC), Asia Pacific Federation of Clinical Biochemistry, ACBI and
AMBI. Her interview has been published in various newspapers and magazines.
Dr. Barnali has many international & national publications, and delivered several invited talks in conferences
in different countries. She has authored one book and contributed many articles in magazines and newspapers. Through her research,
she has proposed a novel index on coronary artery disease named Lipid Pentad Index (LPI). Many newsletters have reviewed her
article on LPI and she was invited to write a commentary on it by the International Atherosclerosis Society. Her
proposed Total Quality Management Protocol in a new laboratory set-up has also received appreciation from AACC. She has successfully
achieved NABL & CAP accreditation as a part of a team at SRL Ranbaxy. She has also served as invited reviewers for AACC, Indian Journal of Clinical Biochemistry and
Indian Journal of Community Medicine.
